Blockade of metastasis formation by CD44-receptor globulin

International Journal of Cancer

Volumn 75, Issue 6, 1998, Pages 919-924

  Zawadzki, Volker ^a   Perschl, Astrid ^a   Rösel, Marc ^a   Hekele, Armin ^a   Zöller, Margot ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; CYTOKINE RECEPTOR; FIBRONECTIN; HERMES ANTIGEN; HYALURONIC ACID; IMMUNOGLOBULIN KAPPA CHAIN; LAMININ; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CANCER INVASION; COLONY FORMATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOHISTOLOGY; LUNG METASTASIS; MELANOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; CELL ADHESION MOLECULES; CELL DIVISION; EXTRACELLULAR MATRIX; LIGANDS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

EID: 0031893321     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980316)75:6<919::AID-IJC15>3.0.CO;2-Y     Document Type: Article

References (29)

1. AHMAD, A. and HART, I.R., Biology of tumor micrometastasis. J. Hematother., 5, 525-535 (1996).
2. BARTOLAZZI, A., PEACH, R., ARUFFO, A. and STAMENKOVIC, I., Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. exp. Med., 180, 53-66 (1994).
3. BECKER, J.C., VARKI, N., GILLIES, S.D., FURUKAWA, K. and REISFELD, R.A., An antibody-interleukin-2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response. Proc. nat. Acad. Sci. (Wash.), 93, 7826-7831 (1996).
4. BENNETT, K.L., MODRELL, B., GREENFIELD, B., BARTOLAZZI, A., STAMENKOVIC, I., PEACH, R., JACKSON, D.G., SPRING, F. and ARUFFO, A., Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol., 131, 1623-1633 (1995).
5. DIETSCH, M.T., SMITH, V.F., COSAND, W.L., DAMLE, N.K., LEDBETTER, J.A., LINSLEY, P.S. and ARUFFO, A., Bi-specific receptor globulins, novel tools for the study of cellular interactions. Preparation and characterization of an E-selectin/P-selectin bi-specific receptor globulin. J. Immunol. Methods, 162, 123-132 (1993).
6. FAASSEN, A.E., MOORADIAN, D.L., TRANQUILLO, R.T., DICKINSON, R.B., LETOURNEAU, P.C., OEGEMA, T.R. and MCCARTHY, J.B., Cell-surface CD44-related chondroitin-sulfate proteoglycan is required for transforming-growth-factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type-I collagen. J. Cell Sci., 105, 501-511 (1993).
7. FIDLER, I.J., Selection of successive tumor lines for metastasis. Nature (Lond.), 242, 148-149 (1973).
8. GUO, Y., MA., J., WANG, J., CHE, X., NARULA, J., BIGBY, M., WU, M. and SLY, M.S., Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res., 54, 1561-1565 (1994).
9. KNUTSON, J.R., IIDA, J., FIELDS, G.B. and MCCARTHY, J.B., CD44/chondroitin-sulfate proteoglycan and alpha2 betal integrin mediate human melanoma-cell migration on type-IV collagen and invasion of basement membranes. Mol. Biol. Cell, 7, 383-396 (1996).
10. LIAO, H.X., LEE, D.M., LEVESQUE, M.C. and HAYNES, B.F., N-terminal and central regions of the human CD44 extracellular domain participate incell-surface hyaluronan binding. J. Imnumol., 155, 3938-3945 (1995).
11. MAEURER, M.J., STORKUS, W.J., KIRKWOOD, J.M. and LOTZE, M.T., New treatment options for patients with melanoma: review of melanoma-derived T-cell-epitope-based peptide vaccines. Melanoma Res., 6, 11-24 (1996).
12. MANTEN-HORST, E., DANEN, E.H., SMIT, L., SNOEK, M., LE POOLE, I.C., VAN MUIJEN, G.N., PALS, S.T. and RUITER, D.J., Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int. J. Cancer (Pred. Oncol.), 64, 182-188 (1995).
13. MAREEL, M.M., VAN ROY, F.M. and BRACKE, M.E., How and when do tumor cells metastasize? Crit. Rev. Oncol., 4, 559-594 (1993).
14. NESBIT, M. and HERLYN, M., Adhesion receptors in human melanoma progression. Invasion Metastasis, 14, 131-146 (1994).
15. REEVES, M.E., ROYAL, R.E., LAM, J.S., ROSENBERG, S.A. and HWU, P., Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res., 56, 5672-5677 (1996).
16. RESTIFO, N.P., MARINCOLA, F.M., KAWAKAMI, Y., TAUBENBERGER, J., YANNELLI, J.R. and ROSKNBERG, S.A., Loss of functional beta-2-microglobulin in metastatic melanoma from five patients receiving immunotherapy. J. nat. Cancer Inst., 17, 100-108 (1996).
17. ROESEL, M., SEITER, S. and ZUELLER, M., CD44v10 expression in the mouse and functional activity in delayed-type hypersensitivity. J. cell. Physiol., 171, 305-317 (1997).
18. SEITER, S., ARCH, R., REBER, S., KOMITOWSKI, D., HOFMANN, M., PONTA, H., HERRLICH, P., MATZKU, S. and ZOELLER, M., Prevention of tumor metastasis formation by anti-variant CD44. J. exp. Med., 177, 443-455 (1993).
19. SEITER, S., SCHADENDORF, D., HERRMANN, K., SCHNEIDER, M., ROESEL, M., ARCH, R., TILGEN, W. and ZOELLER, M., Expression of splice variants of CD44 during melanoma progression. Clin. Cancer Res., 2, 447-456 (1996).
20. SY, M.S., GUO, Y.J. and STAMENKOVIC, I., Inhibition of tumor growth in vivo with a soluble CD44 immunoglobulin fusion protein. J. exp. Med., 176, 623-627 (1992).
21. THOMAS, L., ETOH, T., STAMENKOVIC, I., MIHM, M.C. JR. and BYERS, H.R., Migration of human melanoma cells is related to CD44 expression. J. invest. Dermatol. 100, 115-120 (1993).
22. TOWBIN, H., STAEHELIN, D. and GORDON, J., Electrophoretic transfer from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc. nat. Acad. Sci. (Wash.), 76, 4350-4354 (1979).
23. TRAUNECKER, A., DOLDER, B. and KARJALAINEN, K., A novel approach for preparing anti-T-cell receptor constant region antibodies. Europ. J. Immunol., 16, 851-854 (1986).
24. TRAUNECKER, A., LUEKE, W. and KARJALAINEN, K., Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature (Lond.), 331, 84-86 (1988).
25. TUSZYNSKI, G.P., WANG, T.N. and BERGER, D., Adhesive proteins and the hematogenous spread of cancer. Acta haematol., 97, 29-39 (1997).
26. VAN DEN EYNDE, B., GAUGLER, B., VAN DER BRUGGEN, P., COULIE, P., BRICHARD, V. and BOON, T., Human tumour antigens recognized by T cells: perspectives for new cancer vaccines. Biochem. Soc. Trans., 23, 681-686 (1995).
27. VAN MUIJEN, G.N., DANEN, E.H., VEERKAMP, J.H., RUITER, D.J., LESLEY, J. and VAN DEN HEUVEL, L.P., Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int. J. Cancer. 61, 241-248 (1995).
28. ZAHALKA, M.A., OKON, E., GOSSLAR, U., HOLZMANN, B. and NAOR, D., Lymph-node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J. Immunol., 154, 5345-5355 (1995).
29. ZOELLER, M., Joint features of metastasis formation and lymphocyte maturation and activation. Curr. Top. Micro-biol. Immunol., 213, 215-247 (1996).